Skip to main content
PMC home page
Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 1989 Apr;2(Suppl):S74–S77. doi: 10.1128/cmr.2.suppl.s74

Gonococcal vaccines.

E C Tramont 1
PMCID: PMC358082  PMID: 2655885

Full text

PDF
S74

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Apicella M. A., Westerink M. A., Morse S. A., Schneider H., Rice P. A., Griffiss J. M. Bactericidal antibody response of normal human serum to the lipooligosaccharide of Neisseria gonorrhoeae. J Infect Dis. 1986 Mar;153(3):520–526. doi: 10.1093/infdis/153.3.520. [DOI] [PubMed] [Google Scholar]
  2. Blake M. S., Gotschlich E. C. Gonococcal membrane proteins: speculation on their role in pathogenesis. Prog Allergy. 1983;33:298–313. [PubMed] [Google Scholar]
  3. Buchanan T. M., Eschenbach D. A., Knapp J. S., Holmes K. K. Gonococcal salpingitis is less likely to recur with Neisseria gonorrhoeae of the same principal outer membrane protein antigenic type. Am J Obstet Gynecol. 1980 Dec 1;138(7 Pt 2):978–980. doi: 10.1016/0002-9378(80)91091-1. [DOI] [PubMed] [Google Scholar]
  4. Cannon J. G. Conserved lipoproteins of pathogenic Neisseria species bearing the H.8 epitope: lipid-modified azurin and H.8 outer membrane protein. Clin Microbiol Rev. 1989 Apr;2 (Suppl):S1–S4. doi: 10.1128/cmr.2.suppl.s1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Carbonetti N. H., Simnad V. I., Seifert H. S., So M., Sparling P. F. Genetics of protein I of Neisseria gonorrhoeae: construction of hybrid porins. Proc Natl Acad Sci U S A. 1988 Sep;85(18):6841–6845. doi: 10.1073/pnas.85.18.6841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chen C. Y., Genco C. A., Rock J. P., Morse S. A. Physiology and metabolism of Neisseria gonorrhoeae and Neisseria meningitidis: implications for pathogenesis. Clin Microbiol Rev. 1989 Apr;2 (Suppl):S35–S40. doi: 10.1128/cmr.2.suppl.s35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fohn M. J., Mietzner T. A., Hubbard T. W., Morse S. A., Hook E. W., 3rd Human immunoglobulin G antibody response to the major gonococcal iron-regulated protein. Infect Immun. 1987 Dec;55(12):3065–3069. doi: 10.1128/iai.55.12.3065-3069.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gregg C. R., Melly M. A., McGee Z. A. Gonococcal lipopolysaccharide: a toxin for human fallopian tube mucosa. Am J Obstet Gynecol. 1980 Dec 1;138(7 Pt 2):981–984. doi: 10.1016/0002-9378(80)91092-3. [DOI] [PubMed] [Google Scholar]
  9. Griffiss J. M., Schneider H., Mandrell R. E., Yamasaki R., Jarvis G. A., Kim J. J., Gibson B. W., Hamadeh R., Apicella M. A. Lipooligosaccharides: the principal glycolipids of the neisserial outer membrane. Rev Infect Dis. 1988 Jul-Aug;10 (Suppl 2):S287–S295. doi: 10.1093/cid/10.supplement_2.s287. [DOI] [PubMed] [Google Scholar]
  10. Hagblom P., Segal E., Billyard E., So M. Intragenic recombination leads to pilus antigenic variation in Neisseria gonorrhoeae. Nature. 1985 May 9;315(6015):156–158. doi: 10.1038/315156a0. [DOI] [PubMed] [Google Scholar]
  11. Hendley J. O., Powell K. R., Salomonsky N. L., Rodewald R. R. Electron microscopy of the gonococcal capsule. J Infect Dis. 1981 Jun;143(6):796–802. doi: 10.1093/infdis/143.6.796. [DOI] [PubMed] [Google Scholar]
  12. Hicks C. B., Boslego J. W., Brandt B. Evidence of serum antibodies to Neisseria gonorrhoeae before gonococcal infection. J Infect Dis. 1987 Jun;155(6):1276–1281. doi: 10.1093/infdis/155.6.1276. [DOI] [PubMed] [Google Scholar]
  13. Judd R. C., Tam M., Joiner K. Characterization of protein I from serum-sensitive and serum-resistant transformants of Neisseria gonorrhoeae. Infect Immun. 1987 Jan;55(1):273–276. doi: 10.1128/iai.55.1.273-276.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. KELLOGG D. S., Jr, PEACOCK W. L., Jr, DEACON W. E., BROWN L., PIRKLE D. I. NEISSERIA GONORRHOEAE. I. VIRULENCE GENETICALLY LINKED TO CLONAL VARIATION. J Bacteriol. 1963 Jun;85:1274–1279. doi: 10.1128/jb.85.6.1274-1279.1963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kellogg D. S., Jr, Cohen I. R., Norins L. C., Schroeter A. L., Reising G. Neisseria gonorrhoeae. II. Colonial variation and pathogenicity during 35 months in vitro. J Bacteriol. 1968 Sep;96(3):596–605. doi: 10.1128/jb.96.3.596-605.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Klimpel K. W., Clark V. L. Multiple protein differences exist between Neisseria gonorrhoeae type 1 and type 4. Infect Immun. 1988 Apr;56(4):808–814. doi: 10.1128/iai.56.4.808-814.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lambden P. R., Heckels J. E., James L. T., Watt P. J. Variations in surface protein composition associated with virulence properties in opacity types of Neisseria gonorrhoeae. J Gen Microbiol. 1979 Oct;114(2):305–312. doi: 10.1099/00221287-114-2-305. [DOI] [PubMed] [Google Scholar]
  18. Lund B., Lindberg F., Marklund B. I., Normark S. The PapG protein is the alpha-D-galactopyranosyl-(1----4)-beta-D-galactopyranose-binding adhesin of uropathogenic Escherichia coli. Proc Natl Acad Sci U S A. 1987 Aug;84(16):5898–5902. doi: 10.1073/pnas.84.16.5898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Mandrell R. E., Griffiss J. M., Macher B. A. Lipooligosaccharides (LOS) of Neisseria gonorrhoeae and Neisseria meningitidis have components that are immunochemically similar to precursors of human blood group antigens. Carbohydrate sequence specificity of the mouse monoclonal antibodies that recognize crossreacting antigens on LOS and human erythrocytes. J Exp Med. 1988 Jul 1;168(1):107–126. doi: 10.1084/jem.168.1.107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. McChesney D., Tramont E. C., Boslego J. W., Ciak J., Sadoff J., Brinton C. C. Genital antibody response to a parenteral gonococcal pilus vaccine. Infect Immun. 1982 Jun;36(3):1006–1012. doi: 10.1128/iai.36.3.1006-1012.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. McKenna W. R., Mickelsen P. A., Sparling P. F., Dyer D. W. Iron uptake from lactoferrin and transferrin by Neisseria gonorrhoeae. Infect Immun. 1988 Apr;56(4):785–791. doi: 10.1128/iai.56.4.785-791.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Meyer T. F., Billyard E., Haas R., Storzbach S., So M. Pilus genes of Neisseria gonorrheae: chromosomal organization and DNA sequence. Proc Natl Acad Sci U S A. 1984 Oct;81(19):6110–6114. doi: 10.1073/pnas.81.19.6110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Morse S. A., Chen C. Y., LeFaou A., Mietzner T. A. A potential role for the major iron-regulated protein expressed by pathogenic Neisseria species. Rev Infect Dis. 1988 Jul-Aug;10 (Suppl 2):S306–S310. doi: 10.1093/cid/10.supplement_2.s306. [DOI] [PubMed] [Google Scholar]
  24. Muir L. L., Strugnell R. A., Davies J. K. Proteins that appear to be associated with pili in Neisseria gonorrhoeae. Infect Immun. 1988 Jul;56(7):1743–1747. doi: 10.1128/iai.56.7.1743-1747.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Plaut A. G., Gilbert J. V., Artenstein M. S., Capra J. D. Neisseria gonorrhoeae and neisseria meningitidis: extracellular enzyme cleaves human immunoglobulin A. Science. 1975 Dec 12;190(4219):1103–1105. doi: 10.1126/science.810892. [DOI] [PubMed] [Google Scholar]
  26. Rest R. F., Shafer W. M. Interactions of Neisseria gonorrhoeae with human neutrophils. Clin Microbiol Rev. 1989 Apr;2 (Suppl):S83–S91. doi: 10.1128/cmr.2.suppl.s83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Rice P. A. Molecular basis for serum resistance in Neisseria gonorrhoeae. Clin Microbiol Rev. 1989 Apr;2 (Suppl):S112–S117. doi: 10.1128/cmr.2.suppl.s112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Rice P. A., Vayo H. E., Tam M. R., Blake M. S. Immunoglobulin G antibodies directed against protein III block killing of serum-resistant Neisseria gonorrhoeae by immune serum. J Exp Med. 1986 Nov 1;164(5):1735–1748. doi: 10.1084/jem.164.5.1735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Robertson J. N., Vincent P., Ward M. E. The preparation and properties of gonococcal pili. J Gen Microbiol. 1977 Sep;102(1):169–177. doi: 10.1099/00221287-102-1-169. [DOI] [PubMed] [Google Scholar]
  30. Robinson E. N., Jr, McGee Z. A., Buchanan T. M., Blake M. S., Hitchcock P. J. Probing the surface of Neisseria gonorrhoeae: simultaneous localization of protein I and H.8 antigens. Infect Immun. 1987 May;55(5):1190–1197. doi: 10.1128/iai.55.5.1190-1197.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Rothbard J. B., Fernandez R., Wang L., Teng N. N., Schoolnik G. K. Antibodies to peptides corresponding to a conserved sequence of gonococcal pilins block bacterial adhesion. Proc Natl Acad Sci U S A. 1985 Feb;82(3):915–919. doi: 10.1073/pnas.82.3.915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Schmitt S., Layh G., Buchanan T. B. Surface-exposed antigenic cleavage fragments of Neisseria gonorrhoeae proteins 1A and IB. Infect Immun. 1986 Dec;54(3):841–845. doi: 10.1128/iai.54.3.841-845.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Schoolnik G. K., Fernandez R., Tai J. Y., Rothbard J., Gotschlich E. C. Gonococcal pili. Primary structure and receptor binding domain. J Exp Med. 1984 May 1;159(5):1351–1370. doi: 10.1084/jem.159.5.1351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Schoolnik G. K., Tai J. Y., Gotschlich E. C. A pilus peptide vaccine for the prevention of gonorrhea. Prog Allergy. 1983;33:314–331. [PubMed] [Google Scholar]
  35. Sparling P. F., Cannon J. G., So M. Phase and antigenic variation of pili and outer membrane protein II of Neisseria gonorrhoeae. J Infect Dis. 1986 Feb;153(2):196–201. doi: 10.1093/infdis/153.2.196. [DOI] [PubMed] [Google Scholar]
  36. Strittmatter W., Hitchcock P. J. Isolation and preliminary biochemical characterization of the gonococcal H.8 antigen. J Exp Med. 1986 Dec 1;164(6):2038–2048. doi: 10.1084/jem.164.6.2038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Stromberg N., Deal C., Nyberg G., Normark S., So M., Karlsson K. A. Identification of carbohydrate structures that are possible receptors for Neisseria gonorrhoeae. Proc Natl Acad Sci U S A. 1988 Jul;85(13):4902–4906. doi: 10.1073/pnas.85.13.4902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Swanson J., Bergström S., Barrera O., Robbins K., Corwin D. Pilus- gonococcal variants. Evidence for multiple forms of piliation control. J Exp Med. 1985 Aug 1;162(2):729–744. doi: 10.1084/jem.162.2.729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Swanson J., Kraus S. J., Gotschlich E. C. Studies on gonococcus infection. I. Pili and zones of adhesion: their relation to gonococcal growth patterns. J Exp Med. 1971 Oct 1;134(4):886–906. doi: 10.1084/jem.134.4.886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Swanson J., Robbins K., Barrera O., Koomey J. M. Gene conversion variations generate structurally distinct pilin polypeptides in Neisseria gonorrhoeae. J Exp Med. 1987 Apr 1;165(4):1016–1025. doi: 10.1084/jem.165.4.1016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Teerlink T., Versantvoort H., Beuvery E. C. Antigenic and immunogenic properties of cyanogen bromide peptides from gonococcal outer membrane protein IB. Evidence for the existence of a surface-exposed conserved epitope. J Exp Med. 1987 Jul 1;166(1):63–76. doi: 10.1084/jem.166.1.63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Thongthai C., Sawyer W. D. Studies on the virulence of Neisseria gonorrhoeae. I. Relation of colonial morphology and resistance to phagocytosis by polymorphonuclear leukocytes. Infect Immun. 1973 Mar;7(3):373–379. doi: 10.1128/iai.7.3.373-379.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Todd W. J., Wray G. P., Hitchcock P. J. Arrangement of pili in colonies of Neisseria gonorrhoeae. J Bacteriol. 1984 Jul;159(1):312–320. doi: 10.1128/jb.159.1.312-320.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Tramont E. C. Inhibition of adherence of Neisseria gonorrhoeae by human genital secretions. J Clin Invest. 1977 Jan;59(1):117–124. doi: 10.1172/JCI108608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Tramont E. C., Sadoff J. C., Boslego J. W., Ciak J., McChesney D., Brinton C. C., Wood S., Takafuji E. Gonococcal pilus vaccine. Studies of antigenicity and inhibition of attachment. J Clin Invest. 1981 Oct;68(4):881–888. doi: 10.1172/JCI110343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Virji M., Fletcher J. N., Zak K., Heckels J. E. The potential protective effect of monoclonal antibodies to gonococcal outer membrane protein IA. J Gen Microbiol. 1987 Sep;133(9):2639–2646. doi: 10.1099/00221287-133-9-2639. [DOI] [PubMed] [Google Scholar]
  47. Virji M., Heckels J. E. Role of anti-pilus antibodies in host defense against gonococcal infection studied with monoclonal anti-pilus antibodies. Infect Immun. 1985 Sep;49(3):621–628. doi: 10.1128/iai.49.3.621-628.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Virji M., Zak K., Heckels J. E. Monoclonal antibodies to gonococcal outer membrane protein IB: use in investigation of the potential protective effect of antibodies directed against conserved and type-specific epitopes. J Gen Microbiol. 1986 Jun;132(6):1621–1629. doi: 10.1099/00221287-132-6-1621. [DOI] [PubMed] [Google Scholar]
  49. Virji M., Zak K., Heckels J. E. Outer membrane protein III of Neisseria gonorrhoeae: variations in biological properties of antibodies directed against different epitopes. J Gen Microbiol. 1987 Dec;133(12):3393–3401. doi: 10.1099/00221287-133-12-3393. [DOI] [PubMed] [Google Scholar]
  50. Ward M. E., Lambden P. R., Heckels J. E., Watt P. J. The surface properties of Neisseria gonorrhoeae: determinants of susceptibility to antibody complement killing. J Gen Microbiol. 1978 Oct;108(2):205–212. doi: 10.1099/00221287-108-2-205. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES